Therapeutic problems in elderly patients with hemophilia

Polskie Archiwum Medycyny Wewnetrznej

Volumn 122, Issue 11, 2012, Pages 567-576

  Zawilska, Krystyna ^a   Podolak Dawidziak, Maria ^b  

^a Strus Hospital   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cardiovascular diseases; Hemophilia; Neoplasms; Quality of life; Renal failure

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ACTIVATED PROTHROMBIN COMPLEX; ANALGESIC AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTICOAGULANT AGENT; ANTIVIRUS AGENT; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10A INHIBITOR; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 CONCENTRATE; CLOPIDOGREL; DESMOPRESSIN; DIPYRONE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MORPHINE; PARACETAMOL; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN INHIBITOR; TRAMADOL; TRANEXAMIC ACID; UNINDEXED DRUG; WARFARIN;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; AORTA ATHEROSCLEROSIS; ARTHRITIS; ATHEROSCLEROTIC PLAQUE; BARE METAL STENT; BLEEDING; BLEEDING TENDENCY; BLOOD CLOTTING; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CHADS2 SCORE; COLORECTAL CANCER; CONTINUOUS INFUSION; CORONARY ARTERY CALCIFICATION; DIAGNOSTIC TEST; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; ELASTOGRAPHY; EXTRACORPOREAL CIRCULATION; FIBROSCAN; GENOTYPE; GERIATRIC PATIENT; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART INFARCTION; HEMODIALYSIS; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HEMOPHILIC ARTHROPATHY; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LABORATORY TEST; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LOADING DRUG DOSE; LOW DRUG DOSE; LYMPHOMA; MALE SEXUAL DYSFUNCTION; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ORTHOPEDIC EQUIPMENT; OSTEOPOROSIS; PAIN; PATIENT MONITORING; PERCUTANEOUS CORONARY INTERVENTION; PERITONEAL DIALYSIS; PHYSICAL ACTIVITY; PHYSIOTHERAPY; POLAND; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; QUALITY OF LIFE; RADIAL ARTERY; RECOMMENDED DRUG DOSE; REHABILITATION CARE; REVIEW; RISK REDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYNOVECTOMY; THROMBOSIS PREVENTION; UNSTABLE ANGINA PECTORIS; VASCULAR ACCESS; VASCULAR DISEASE; VON WILLEBRAND DISEASE;

EID: 84872325318     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1466     Document Type: Review

References (64)

1. Darby SC, Kan SW, Spooner RJ, et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood. 2007; 110: 815-825.
2. Central Statistical Office. Concise Statistical Yearbook of Poland. Year LII. PPWK Capital Group. 23.07.2009.
3. Zdziarska J, Chojnowski K, Klukowska A, et al. Registry of inherited bleeding disorders in Poland-current status and potential role of the HemoRec database. Haemophilia. 2011; 17: 189-195.
4. Windyga J, Łopaciuk S, Stefańska E, Klukowska A. [Hemophilia and other inherited coagulation disorders in Poland]. Pol Arch Med Wewn. 2004; 112: 1197-1202. Polish.
5. Dolan G. The challenge of an ageing haemophilic population. Haemophilia. 2010; 16 Suppl 5: 11-16.
6. Franchini M, Tagliaferri A, Mannucci PM. The management of hemophilia in elderly patients. Clin Interv Aging. 2007; 2: 361-368.
7. Windyga J, Grabarczyk P, Stefañska E, et al. [Prevalence of HCV, HBV and HIV infections among severe Polish haemophiliacs]. Przegl Epidemiol. 2008; 62: 415-423. Polish.
8. Plug I, Van Der Born JG, Peters M, et al. Mortality and causes of death in patients with haemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost. 2006; 4: 510-516.
9. Khleif AA, Rodrigez N, Brown D, Escobar MA. Multiple comorbid conditions among middle-aged and elderly haemophilia patients: prevalence estimates and implications for future care. J Aging Res. 2011; 2011: 985 703.
10. Posthouwer D, Makris M, Yee TT, et al. Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multi-center cohort-study. Blood. 2007; 109: 3667-3671.
11. Shin JL, Teitel J, Swain MG, et al. A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: is it safe and useful? Am J Hematol. 2005; 78: 85-93.
12. Makris M, Dusheiko G. Hepatitis and hemophilia. In: Lee Ch, Berntorp E, Hoots K, (eds). Textbook of Haemophilia. 2nd ed. Wiley-Blackwell Publishing Ltd.: Chichester, United Kingdom; Haboken, New Jersey; 2010: 215-221.
13. Posthouwer D, Mauser-Bunschoten EP, Fischer K, et al. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography. J Thromb Haemost. 2007; 5: 25-30.
14. Posthouwer D, Mauser-Bunschoten EP, Fischer K. Liver biopsy in patients with haemophilia: in search for a reliable, non-invasive alternative. Haemophilia. 2008; 14: 647-648.
15. Mauser-Bunschoten EP, Posthouwer D, De Knegt RJ. Hepatitis C in haemophilia: natural history and treatment. In: Mauser-Bunschoten EP, De Knecht-Van Eekelen A, Smit C (eds). Aging with haemophilia. Medical and psychosocial impact. Utrecht, Netherlands: Van Creveldkliniek-Hematology; 2007: 47-53.
16. Posthouwer D, Yee TT, Fischer TT, et al. Antiviral therapy for chronic hepatitis in patients with inherited bleeding disorders: an international, multicenter cohort study. J Thromb Haemost. 2007; 5: 1624-1628.
17. Seeff IB. The history of the "natural history" of hepatitis C (1968-2009). Liver Int. 2009; 29 Suppl 1: 89-99.
18. Meijer K, Haagsma EB. HCV-related liver cancer in people with haemophilia. Haemophilia. 2012; 18: 17-24.
19. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003; 362: 1907-1917.
20. Magdzik WW. Hepatitis B epidemiology in Poland, Central and Eastern Europe and the newly independent states. Vaccine. 2000; 18 Suppl 1: S13-16.
21. Magdzik W, Czarkowski MP. [Epidemiological situation of hepatitis B in Poland in the year 1979-2004]. Przegla̧d Epidemiol. 2006; 60: 471-480. Polish.
22. Tradati F, Colombo M, Mannucci PM, et al. A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers. Blood. 1998; 91: 1173-1177.
23. Bontempo FA, Lewis JH, Gorenc TJ, et al. Liver transplantation in hemophilia A. Blood. 1987; 69: 1721-1724.
24. Dzik WH, Laposata M, Hertl M, et al. Case records of the Massachusetts General Hospital. Case 38-2008. A 58-year-old man with hemophilia, hepatocellular carcinoma, and intractable bleeding. N Engl J Med. 2008; 359: 2567-2597.
25. Au WY, Liu CL, Lo CM, et al. Living donor liver transplantation for hepatitis C related hepatocellular carcinoma in a haemophilia A patient. Haemophilia. 2005; 11: 405-407.
26. Wilde J, Teixeira P, Bramhall SR, et al. Liver transplantation in haemophilia. Br J Haematol. 2002; 117: 952-956.
27. Anderson G, Horvath J. The growing burden of chronic disease in America. Public Health Rep. 2004; 119: 263-270.
28. Girolami A, Ruzzon E, Fabris F, et al. Myocardial infarction and other arterial occlusions in hemophilia patients. A cardiological evaluation of all 42 cases reported in the literature. Acta Haematol. 2006; 116: 120-125.
29. Biere-Rafi S, Baarslag MA, Peters M, et al. Cardiovascular risk assessment in haemophilia patients. Thromb Haemost. 2011; 105: 274-278.
30. Foley C J, Nichols L, Jeong K, et al. Coronary atherosclerosis and cardiovascular mortality in haemophilia. J Thromb Haemost. 2010; 8: 208-211.
31. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008; 358: 580-591.
32. Lim MY, Pruthi RK. Impact of lifestyle modifications on symptomatic coronary artery disease in a haemophilia patient with inhibitors. Haemophilia. 2011; 17: e1006-e1007.
33. Tuinenburg A, Mauser-Bunschoten EP, Verhaar MC, et al. Cardiovascular disease in patients with hemophilia. J Thromb Haemost. 2009; 7: 247-254.
34. Mannucci PM. Management of antithrombotic therapy for acute coronary syndrome and atrial fibrillation in patients with hemophilia. Expert Opin Pharmacother. 2012; 13: 505-510.
35. Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010; 1237: 263-272.
36. Mannucci PM, Schutgens RE, Sangostino E, et al. How I treat morbidities in elderly persons with hemophilia. Blood. 2009;114: 5256-5263.
37. Lim MY, Pruthi RK. Outcome of management of acute coronary syndrome in patients with congenital bleeding disorders: a single center experience and review of the literature. Thromb Res. 2012; 3: 316-322.
38. Walsh M, Macgregor D, Stuckless S, et al. Health-related quality of life in a cohort of adult patients with mild hemophilia A. J Thromb Haemost. 2008; 6: 755-761.
39. Stieltjes N, Calvez T, Domiguel V, et al.; French ICH Study Group. Intracranial haemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death. Haemophilia. 2005; 11: 452-458.
40. Ljung RC. Intracranial haemorrhage in haemophilia A and B. Br J Haematol. 2008; 140: 378-384.
41. Mauser-Bunschoten EP, Schutgens REG. Haemophilia and medicine in old age. In: Lee Ch, Berntorp E, Hoots K, (eds). Textbook of Haemophilia. 2nd ed. Wiley-Blackwell Publishing Ltd.: Chichester, United Kingdom; Haboken, New Jersey; 2010: 138-145.
42. Kulkarni R, Soucie JM, Evatt BL; Hemophilia Surveillance System Project Investigators. Renal disease among males with haemophilia. Haemophilia. 2003; 9: 703-710.
43. Jones R, Scott C, Nelson M, Levy J. Renal complications in HIV. Int J Clin Pract. 2007; 61: 991-998.
44. Koene RA, Gerlag PG, Jansen JL, et al. Successful hemodialysis and renal transplantation in a patient with haemophilia A. Proc Eur Dial Transplant Assoc. 1977; 14: 401-406.
45. Kusztel M, Kuzniar J, Weyde W, Klinger M. Haemodialysis in a patient with haemophilia B. Nephrol Dial Transplant. 2008; 23: 424-425.
46. Roy-Chaudhury P, Propper DJ, Catto GR. Renal replacement therapy for haemophiliacs. J Nephrol. 1993; 6: 93-94.
47. Bajo MA, del Peso G, Jimenez V, et al. Peritoneal dialysis is the therapy of choice of end-stage renal disease patients with hereditary clotting disorders. Adv Perit Dial. 2000; 16: 170-173.
48. Hofstede FG, Fijnvandraat K, Plug I, et al. Obesity: a new disaster for haemophilic patients? A nationwide survey. Haemophilia. 2008; 14: 1035-1038.
49. Wallny TA, Scholz DT, Oldenburg J, et al. Osteoporosis in haemophilia - an underestimated comorbidity? Haemophilia. 2007; 13: 79-84.
50. Siboni SM, Mannucci PM, Gringeri A, et al.; Italian Association of Haemophilia Centres (AICE). Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost. 2009; 7: 780-786.
51. Windyga J, Lopaciuk S, Stefanska E, et al. Haemophilia in Poland. Haemophilia. 2006; 12: 52-57.
52. Franchini A, Mannucci PM. Thrombin and cancer: from molecular basis to therapeutic implications. Semin Thromb Hemost. 2012; 38: 95-101.
53. Franchini M. Haemophilia and cancer: a personal perspective. Blood Transfus. 2012 Jul 4: 1-6. [Epub ahead of print].
54. Langer F, Amirkhosravi A, Ingersoll SB, et al. Experimental metastasis and primary tumor growth in mice with hemophilia A. J Thromb Haemost. 2006; 4: 1056-1062.
55. Walker IR, Julian JA. Causes of death in Canadians with haemophilia, 1980-1995. Association of Hemophilia Clinic Directors of Canada. Haemophilia. 1998; 4: 714-720.
56. Tagliaferri A, Rivolta GP, Iorio A, et al. Mortality and causes of death in Italian persons with haemophilia, 1990-2007. Haemophilia. 2010; 16: 437-446.
57. Miesbach W, Seifried E. Does haemophilia influence cancer-related mortality in HIV-negative patients? Haemophilia. 2011; 17: 55-60.
58. Darby SC, Keeling DM, Spooner RJ, et al. UK Haemophilia Centre Doctors' Organization. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality. J Thromb Haemost. 2004; 2: 1047-1054.
59. Philipp C. The aging patients with hemophilia: complications, comorbidities, and management issues. Am Soc Hematol Educ Program. 2010; 191-196.
60. Szczepanik AB, Wisławski S, Windyga J, et al. [Strategy for secure hemostasis in hemophilia patients undergoing surgery for malignant neoplasms]. Pol Merkur Lekarski. 2009; 27: 375-380. Polish.
61. Zatorska K, Orłowska-Baranowska E, Abramczuk E, et al. Short and long-term management of haemophilia A patient requiring heart valve surgery. Haemophilia. 2012; 18: e352-e354.
62. Bar-Chama N, Snyder S, Aledort L. Sexual evaluation and treatment of aging males with haemophilia. Haemophilia. 2011; 17: 875-883.
63. Walsh M, Macgregor D, Stuckless, et al. Health-related quality of life in a cohort of adult patients with mild hemophilia A. J Thromb Haemost. 2008; 6: 755-761.
64. Jończyk H, Reczek A, Brzostek T, Zdziarska J. [Quality of life of patients type A hemophilia]. Problemy Pielȩgniarstwa. 2009; 17: 116-122. Polish.